| BLR1 |
BLR1, CXCR5, MDR15: C-X-C chemokine receptor type 5 |
GPR17 |
IPI00012717 |
0.49 |
Evidence |
|
| CCR7 |
CCR7, CMKBR7, EBI1, EVI1: C-C chemokine receptor type 7 precursor |
AGTR2 |
AGTR2: Type-2 angiotensin II receptor |
0.49 |
Evidence |
|
| CCR1 |
CCR1, CMKBR1, CMKR1, SCYAR1: C-C chemokine receptor type 1 |
CCRL1 |
CCRL1, CCBP2, CCR11, VSHK1: C-C chemokine receptor type 11 |
0.49 |
Evidence |
|
| CCR1 |
CCR1, CMKBR1, CMKR1, SCYAR1: C-C chemokine receptor type 1 |
GPR3 |
GPR3, ACCA: Probable G-protein coupled receptor 3 |
0.49 |
Evidence |
|
| F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
GPR17 |
IPI00012717 |
0.49 |
Evidence |
|
| EDNRA |
EDNRA, ETA, ETRA: Endothelin-1 receptor precursor |
OR1G1 |
OR1G1, OR1G2: Olfactory receptor 1G1 |
0.49 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
EDG7 |
EDG7, LPA3: Lysophosphatidic acid receptor Edg-7 |
0.49 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
OR1G1 |
OR1G1, OR1G2: Olfactory receptor 1G1 |
0.49 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
C14orf21 |
LTB4R2, BLT2R, BLTR2: Leukotriene B4 receptor 2 |
0.49 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
EDG2 |
EDG2, LPA1: Lysophosphatidic acid receptor Edg-2 |
0.49 |
Evidence |
|
| IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
OR1D2 |
OR1D2, OLFR1: Olfactory receptor 1D2 |
0.49 |
Evidence |
|
| LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
0.49 |
Evidence |
|
| DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
0.49 |
Evidence |
|
| DRD5 |
DRD5, DRD1B, DRD1L2: D(1B) dopamine receptor |
FPRL1 |
FPRL1, FPR2, FPRH1, LXA4R: FMLP-related receptor I |
0.49 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
0.49 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
P2RY11 |
P2RY11: P2Y purinoceptor 11 |
0.49 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
OR1G1 |
OR1G1, OR1G2: Olfactory receptor 1G1 |
0.49 |
Evidence |
|
| CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
HTR6 |
HTR6: 5-hydroxytryptamine receptor 6 |
0.49 |
Evidence |
|
| TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
ATF5 |
ATF5, ATFX: Cyclic AMP-dependent transcription factor ATF-5 |
0.49 |
Evidence |
|
| HLA-DPA1 |
HLA-DPA1, HLA-DP1A, HLASB: HLA class II histocompatibility antigen, DP alpha cha |
ALB |
ALB: Uncharacterized protein ALB |
0.49 |
Evidence |
|
| ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
EDG8 |
EDG8: Sphingosine 1-phosphate receptor Edg-8 |
0.49 |
Evidence |
|
| ADRA2C |
ADRA2C, ADRA2L2, ADRA2RL2: Alpha-2C adrenergic receptor |
CHRM3 |
CHRM3: Muscarinic acetylcholine receptor M3 |
0.49 |
Evidence |
|
| ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
C14orf21 |
LTB4R2, BLT2R, BLTR2: Leukotriene B4 receptor 2 |
0.49 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
ALB |
ALB: Uncharacterized protein ALB |
0.49 |
Evidence |
|
| ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
HRH4 |
HRH4, GPCR105: Histamine H4 receptor |
0.49 |
Evidence |
|